Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Wegovy by Novo Nordisk for Diastolic Heart Failure (HFpEF): Likelihood of Approval
Wegovy is under clinical development by Novo Nordisk and currently in Pre-Registration for Diastolic Heart Failure (HFpEF). According to GlobalData,...